Zobrazeno 1 - 4
of 4
pro vyhledávání: '"T. I. Trivedi"'
Autor:
N G, Shah, T I, Trivedi, R A, Tankshali, J A, Goswami, D H, Jetly, T P, Kobawala, S N, Shukla, P M, Shah, R J, Verma
Publikováno v:
The International Journal of Biological Markers. 21:175-183
The present study sought to explore the occurrence of signal transducer and activator of transcription 3 (Stat3) in patients with oral squamous cell carcinoma (n=135) and its potential relationship with clinicopathological parameters and survival. St
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fe485d55be3a0ec05a46a0bfd6a6ff6
https://doi.org/10.1177/172460080602100307
https://doi.org/10.1177/172460080602100307
Publikováno v:
The International Journal of Biological Markers. 21:74-80
There is growing interest in assessing multistep carcinogenesis and predicting its course using different molecular markers. TP53 is a tumor suppressor gene and appears to be one of the molecular targets of tobacco-related carcinogens in oral cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa6cae0e36952ff8f617f92d132c61e7
https://doi.org/10.1177/172460080602100202
https://doi.org/10.1177/172460080602100202
Autor:
T. I Trivedi, T. P. Suthar, Devendra D. Patel, Hemangini H. Vora, N. Ghosh, P. R. Chikhlikar, Bhatavdekar Jm, N. G. Shah
Publikováno v:
European Journal of Surgical Oncology (EJSO). 26:540-547
Aims: The aim of this study was to evaluate the prognostic value of pre-operative prolactin (PRL) in conjunction with established prognosticators, and the risk of disease relapse in patients with early and advanced breast cancer. To confirm the hypot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d2a843e3827fa5c2250f3419250a619
https://doi.org/10.1053/ejso.2000.0943
https://doi.org/10.1053/ejso.2000.0943
Autor:
N. G. Shah, T. I. Trivedi
Publikováno v:
Methods of Cancer Diagnosis, Therapy, and Prognosis ISBN: 9789048131853
Head and neck cancer accounts for 5-10% of all tumors, and cancer of the oral cavity accounts for 30% of all head and neck cancers. Currently, nodal status is the single most important clinical prognostic indicator for survival. While the 5 year surv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91f56df7c38f17dc0fce93722a8bfca1
https://doi.org/10.1007/978-90-481-3186-0_17
https://doi.org/10.1007/978-90-481-3186-0_17
